Sign in
8-K

Current Report

LENZ Therapeutics, Inc. Filed Acc 0001628280-25-016824

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading lenz-20250404.htm…